Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 1, 1996, Pages 57-62

  Walmrath, Dieter ^a   Günther, Andreas ^a   Ghofrani, Hossein Ardeschir ^a   Schermuly, Ralph ^a   Schneider, Thomas ^a   Grimminger, Friedrich ^a   Seeger, Werner ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL OXYGEN SATURATION; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CLINICAL ARTICLE; FEMALE; GAS EXCHANGE; HUMAN; LUNG ALVEOLUS SURFACE TENSION; LUNG LAVAGE; MALE; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE; TOPICAL DRUG ADMINISTRATION;

EID: 0030036989     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.1.8680699     Document Type: Article

References (22)

1. Murray, J. F., M. A. Matthay, J. M. Luce, and M. R. Flick. 1988. An expanded definition of the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 138:720-723.
2. Jobe, A. H. 1993. Pulmonary surfactant therapy. N. Engl. J. Med. 328:861-868.
3. Seeger, W., A. Günther, H. D. Walmrath, F. Grimminger, and H. G. Lasch. 1993. Alveolar surfactant and adult respiratory distress syndrome: pathogenetic role and therapeutic prospects. Clin. Invest. 71: 177-190.
4. Eijking, E. P., G. J. Van Daal, R. Tenbrinck, J. F. Sluiters, E. Hannapel, W. Erdmann, and B. Lachmann. 1991. Improvement of pulmonary gas exchange after surfactant replacement in rats with pneumocystis carinii pneumonia. Intensive Care Med. 17:475-478.
5. Eijking, E. P., D. Gommers, K. L. So, M. Vergeer, and B. Lachmann. 1993. Surfactant treatment of respiratory failure induced by hydrochloric acid aspiration in rats. Anesthesiology 78:1145-1151.
6. Haslam, P. L., D. A. Hughes, P. D. MacNaughton, C. S. Baker, and T. W. Evans. 1994. Surfactant replacement therapy in late-stage adult respiratory distress syndrome. Lancet 343:1009-1011.
7. Spragg, R. G., N. Gilliard, P. Richmann, R. M. Smith, R. Duncan Hite, D. Pappert, B. Robertson, T. Curstedt, and D. Strayer. 1994. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 105:195-202.
8. Weg, J. G., R. A. Balk, R. S. Tharratt, S. G. Jenkinson, J. B. Shah, D. Zaccardelli, J. Horton, and E. N. Pattishall. 1994. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. J.A.M.A. 272:1433-1438.
9. Zapol, W. M., M. T. Snider, J. D. Hill, R. J. Fallat, R. H. Bartlett, L. H. Edmunds, A. H. Morris, E. C. C. I. I. Peirce, A. N. Thomas, H. J. Proctor, P. A. Drinker, P. C. Pratt, A. Bagniewski, and R. G. Miller. 1979. Extracorporeal membrane oxygenation in severe acute respiratory failure. J.A.M.A. 242:2193-2196.
10. U.S. National Heart, Lung and Blood Institute. 1979. Extracorporeal support for respiratory insufficiency: a collaborative study in response to RFP-NHL1-73-20; Appendices 1 and 2. U.S. Department of Health, Education and Welfare, National Institutes of Health, Bethesda, MD. 247-264.
11. Wagner, P. D., H. A. Saltzman, and J. B. West. 1974. Measurement of continuous distributions of ventilation perfusion ratios: theory. J. Appl. Physiol. 36:588-599.
12. Krämer, H. J., R. Schmidt, A. Günther, G. Becker, Y. Suzuki, and W. Seeger. 1995. Elisa technique for quantification of Surfactant-Protein B (SP-B) in bronchoalveolar lavage fluid. Am. J. Respir. Crit. Care Med. 152:1540-1544.
13. Honda, Y., H. Takahashi, N. Shijubo, Y. Kuroki, and T. Akino. 1993. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis. Chest 103:496-499.
14. Günther, A., C. Siebert, R. Schmidt, S. Ziegler, F. Grimminger, M. Yabut, B. Temmesfeld, D. Walmrath, H. Morr, and W. Seeger. 1996. Surfactant alterations in severe pneumonia, ARDS and cardiogenic lung edema. Am. J. Respir. Crit. Care Med. 153:176-184.
15. U.S. National Heart, Lung and Blood Institute. 1979. Extracorporeal support for respiratory insufficiency: a collaborative study in response to RFP-NHLI-73-20; Appendices 9 and 10. U.S. Department of Health, Education and Welfare, National Institutes of Health, Bethesda, MD. 305-370.
16. Gregory, T. J., W. J. Longmore, M. A. Moxley, J. A. Whitsett, C. R. Reed, A. A. Fowler III, L. D. Hudson, R. A. Maunder, C. Crim, and T. M. Hyers. 1991. Surfactant chemcial composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88:1976-1981.
17. Hallman, M., R. Spragg, J. H. Harrell, M. Moser, and L. Gluck. 1982. Evidence of lung surfactant abnormality in respiratory failure: study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J. Clin. Invest. 70:673-683.
18. Pison, U., W. Seeger, R. Buchhorn, T. Joka, M. Brand, U. Obertacke, H. Neuhof, and K.-P. Schmit-Neuerburg. 1989. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am. Rev. Respir. Dis. 140:1033-1039.
19. Gregory, T. J., J. E. Gadek, J. E. Weiland, T. M. Hyers, C. Crim, L. D. Hudson, K. P. Steinberg, R. A. Maunder, R. G. Spragg, R. M. Smith, D. F. Tierney, B. Gipe, W. J. Longmore, and M. A. Moxley. 1994. Survanta® supplementation in patients with acute respiratory distress syndrome (ARDS) (abstract). Am. J. Respir. Crit. Care Med. 149:A567.
20. Artigas, A., J. Carlet, J. Le Gall, C. Chastang, L. Blanch, and R. Fernandez. 1991. Clinical presentation, prognostic factors, and outcome of ARDS in the European collaborative study (1985-1987): a preliminary report. In W. Zapol, F. Lemaire, editors. Adult Respiratory Distress Syndrome. Marcel Dekker, New York. 37-63.
21. 2 removal for adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 149:295-305.
22. Zapol, W. M. 1991. A nordic ECMO saga or whither ECMO? Intensive Care Med. 17:69-70.